Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor

Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor

Cyclin-dependent kinases have emerged as important targets for cancer therapy. HSD992, containing a novel scaffold based on the tetrahydro-3H-pyrazolo[4,3-a]phenanthridine core, inhibits CDK2/3 but not other CDKs and also potently inhibits several cancer cell lines.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical communications (Cambridge, England) England), 2018-05, Vol.54 (36), p.4521-4524
Hauptverfasser: Opoku-Temeng, Clement, Dayal, Neetu, Hernandez, Delmis E, Naganna, N, Sintim, Herman O
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Cyclin-dependent kinases
Kinases
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4524
container_issue 36
container_start_page 4521
container_title Chemical communications (Cambridge, England)
container_volume 54
creator Opoku-Temeng, Clement
Dayal, Neetu
Hernandez, Delmis E
Naganna, N
Sintim, Herman O
description Cyclin-dependent kinases have emerged as important targets for cancer therapy. HSD992, containing a novel scaffold based on the tetrahydro-3H-pyrazolo[4,3-a]phenanthridine core, inhibits CDK2/3 but not other CDKs and also potently inhibits several cancer cell lines.
doi_str_mv 10.1039/c8cc01154k
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2023411415</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2032695044</sourcerecordid><originalsourceid>FETCH-LOGICAL-p169t-a8147416433048487915c8eb63f429da3e0a024ef9073d561be9840ef56d46d53</originalsourceid><addsrcrecordid>eNpd0M9LwzAUB_AgipvTi3-ADLx4MJofL2lyEpk_Jg68TBBEStqktLNratIe5l9vh_Piu7zv4cPjy0PolJIrSri-zlWeE0oFfO6hMeUSsAD1tr_NQuOEgxihoxhXZBgq1CEaMS2ZBoAxulm6LphyY4PHfI7bTTDfvvbvcMmx-WhL15imK0Nlq8bhzERnp7O752nVlFVWdT4co4PC1NGd7PYEvT7cL2dzvHh5fJrdLnBLpe6wURQSoBI4J6BAJZqKXLlM8gKYtoY7YggDV2iScCskzZxWQFwhpAVpBZ-gi9-7bfBfvYtduq5i7uraNM73MWWEcaAU6Jae_6Mr34dmaDcozqQWBGBQZzvVZ2tn0zZUaxM26d9r-A8V_WIJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2032695044</pqid></control><display><type>article</type><title>Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor</title><source>Royal Society Of Chemistry Journals</source><source>Alma/SFX Local Collection</source><creator>Opoku-Temeng, Clement ; Dayal, Neetu ; Hernandez, Delmis E ; Naganna, N ; Sintim, Herman O</creator><creatorcontrib>Opoku-Temeng, Clement ; Dayal, Neetu ; Hernandez, Delmis E ; Naganna, N ; Sintim, Herman O</creatorcontrib><description>Cyclin-dependent kinases have emerged as important targets for cancer therapy. HSD992, containing a novel scaffold based on the tetrahydro-3H-pyrazolo[4,3-a]phenanthridine core, inhibits CDK2/3 but not other CDKs and also potently inhibits several cancer cell lines.</description><identifier>ISSN: 1359-7345</identifier><identifier>EISSN: 1364-548X</identifier><identifier>DOI: 10.1039/c8cc01154k</identifier><identifier>PMID: 29629444</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Cancer ; Cyclin-dependent kinases ; Kinases</subject><ispartof>Chemical communications (Cambridge, England), 2018-05, Vol.54 (36), p.4521-4524</ispartof><rights>Copyright Royal Society of Chemistry 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-8140-4637 ; 0000-0002-2280-9359</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29629444$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Opoku-Temeng, Clement</creatorcontrib><creatorcontrib>Dayal, Neetu</creatorcontrib><creatorcontrib>Hernandez, Delmis E</creatorcontrib><creatorcontrib>Naganna, N</creatorcontrib><creatorcontrib>Sintim, Herman O</creatorcontrib><title>Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor</title><title>Chemical communications (Cambridge, England)</title><addtitle>Chem Commun (Camb)</addtitle><description>Cyclin-dependent kinases have emerged as important targets for cancer therapy. HSD992, containing a novel scaffold based on the tetrahydro-3H-pyrazolo[4,3-a]phenanthridine core, inhibits CDK2/3 but not other CDKs and also potently inhibits several cancer cell lines.</description><subject>Cancer</subject><subject>Cyclin-dependent kinases</subject><subject>Kinases</subject><issn>1359-7345</issn><issn>1364-548X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpd0M9LwzAUB_AgipvTi3-ADLx4MJofL2lyEpk_Jg68TBBEStqktLNratIe5l9vh_Piu7zv4cPjy0PolJIrSri-zlWeE0oFfO6hMeUSsAD1tr_NQuOEgxihoxhXZBgq1CEaMS2ZBoAxulm6LphyY4PHfI7bTTDfvvbvcMmx-WhL15imK0Nlq8bhzERnp7O752nVlFVWdT4co4PC1NGd7PYEvT7cL2dzvHh5fJrdLnBLpe6wURQSoBI4J6BAJZqKXLlM8gKYtoY7YggDV2iScCskzZxWQFwhpAVpBZ-gi9-7bfBfvYtduq5i7uraNM73MWWEcaAU6Jae_6Mr34dmaDcozqQWBGBQZzvVZ2tn0zZUaxM26d9r-A8V_WIJ</recordid><startdate>20180504</startdate><enddate>20180504</enddate><creator>Opoku-Temeng, Clement</creator><creator>Dayal, Neetu</creator><creator>Hernandez, Delmis E</creator><creator>Naganna, N</creator><creator>Sintim, Herman O</creator><general>Royal Society of Chemistry</general><scope>NPM</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8140-4637</orcidid><orcidid>https://orcid.org/0000-0002-2280-9359</orcidid></search><sort><creationdate>20180504</creationdate><title>Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor</title><author>Opoku-Temeng, Clement ; Dayal, Neetu ; Hernandez, Delmis E ; Naganna, N ; Sintim, Herman O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p169t-a8147416433048487915c8eb63f429da3e0a024ef9073d561be9840ef56d46d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cancer</topic><topic>Cyclin-dependent kinases</topic><topic>Kinases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Opoku-Temeng, Clement</creatorcontrib><creatorcontrib>Dayal, Neetu</creatorcontrib><creatorcontrib>Hernandez, Delmis E</creatorcontrib><creatorcontrib>Naganna, N</creatorcontrib><creatorcontrib>Sintim, Herman O</creatorcontrib><collection>PubMed</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical communications (Cambridge, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Opoku-Temeng, Clement</au><au>Dayal, Neetu</au><au>Hernandez, Delmis E</au><au>Naganna, N</au><au>Sintim, Herman O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor</atitle><jtitle>Chemical communications (Cambridge, England)</jtitle><addtitle>Chem Commun (Camb)</addtitle><date>2018-05-04</date><risdate>2018</risdate><volume>54</volume><issue>36</issue><spage>4521</spage><epage>4524</epage><pages>4521-4524</pages><issn>1359-7345</issn><eissn>1364-548X</eissn><abstract>Cyclin-dependent kinases have emerged as important targets for cancer therapy. HSD992, containing a novel scaffold based on the tetrahydro-3H-pyrazolo[4,3-a]phenanthridine core, inhibits CDK2/3 but not other CDKs and also potently inhibits several cancer cell lines.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>29629444</pmid><doi>10.1039/c8cc01154k</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-8140-4637</orcidid><orcidid>https://orcid.org/0000-0002-2280-9359</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1359-7345
ispartof Chemical communications (Cambridge, England), 2018-05, Vol.54 (36), p.4521-4524
issn 1359-7345
1364-548X
language eng
recordid cdi_proquest_miscellaneous_2023411415
source Royal Society Of Chemistry Journals; Alma/SFX Local Collection
subjects Cancer
Cyclin-dependent kinases
Kinases
title Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T00%3A34%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tetrahydro-3H-pyrazolo%5B4,3-a%5Dphenanthridine-based%20CDK%20inhibitor&rft.jtitle=Chemical%20communications%20(Cambridge,%20England)&rft.au=Opoku-Temeng,%20Clement&rft.date=2018-05-04&rft.volume=54&rft.issue=36&rft.spage=4521&rft.epage=4524&rft.pages=4521-4524&rft.issn=1359-7345&rft.eissn=1364-548X&rft_id=info:doi/10.1039/c8cc01154k&rft_dat=%3Cproquest_pubme%3E2032695044%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2032695044&rft_id=info:pmid/29629444&rfr_iscdi=true